The Cooper Companies, Inc.
A maker of contact lenses and fertility and women's-health products, The Cooper Companies runs two businesses: CooperVision, with brands like Biofinity, MyDay, and clariti 1 day, and CooperSurgical, maker of the Paragard hormone-free IUD and IVF devices. It began in 1958 when a Wall Street lawyer named Parker Montgomery bought a small healthcare firm, later renaming it Cooper Laboratories and then The Cooper Companies. Its MiSight 1 day lens is the only contact lens the FDA has approved to slow nearsightedness in children.
Granted 382.5K · Sold 371.2K
Granted 235.9K · Bought 20.0K · Sold 115.0K
Granted 233.1K · Bought 3.0K · Sold 187.6K
Granted 33.6K · Bought 1.2K
Granted 17.3K
Granted 7.3K
Granted 56.9K · Bought 1.5K · Sold 29.8K
Granted 27.3K · Bought 1.4K · Sold 1.2K
Granted 1.7K · Sold 1.7K
Granted 10.3K
Granted 10.1K · Bought 1.0K
Granted 9.4K · Bought 1.8K
Granted 4.4K · Sold 4.7K
Granted 7.1K · Bought 4.0K
Granted 832
Granted 70.4K · Sold 62.9K
Granted 3.5K
Granted 3.0K
Granted 1.1K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Weiss Robert SDirector · 36 transactions | — | 550.5K | 382.5K | — | 371.2K |
| White Albert G IIIPresident & CEO, Director · 11 transactions | +419.7% | 254.5K | 235.9K | 20.0K | 115.0K |
| McBride Daniel GEVP & Chief Operating Officer · 31 transactions | — | 166.0K | 233.1K | 3.0K | 187.6K |
| Sheffield Holly RPresident, CSI · 23 transactions | +1824.4% | 47.1K | 33.6K | 1.2K | — |
| Jay ColleenDirector · 6 transactions | +758.8% | 39.9K | 17.3K | — | — |
| Kozy William ADirector · 4 transactions | +533.5% | 31.1Kas of Apr 2025 | 7.3K | — | — |
| Andrews Brian GEVP, CFO & Treasurer · 24 transactions | — | 30.7K | 56.9K | 1.5K | 29.8K |
| Warner Gerard H IIIPresident, CooperVision, Inc. · 44 transactions | — | 21.0K | 27.3K | 1.4K | 1.2K |
| Lindell Jody SDirector · 4 transactions | 0% | 19.8Kas of Jan 2023 | 1.7K | — | 1.7K |
| Madden Teresa SDirector · 5 transactions | +4304.2% | 15.7K | 10.3K | — | — |
| Rivas MariaDirector · 8 transactions | — | 14.5K | 10.1K | 1.0K | — |
| Lucchese Cynthia LDirector · 5 transactions | — | 12.8K | 9.4K | 1.8K | — |
| Petersmeyer Gary SDirector · 22 transactions | — | 12.4Kas of Mar 2024 | 4.4K | — | 4.7K |
| Kurzius Lawrence ErikDirector · 5 transactions | — | 11.1K | 7.1K | 4.0K | — |
| Rosebrough Walter M JrDirector · 1 transaction | — | 10.8K | 832 | — | — |
| Ricupati AgostinoSVP & CAO · 39 transactions | +533.8% | 8.0Kas of Apr 2025 | 70.4K | — | 62.9K |
| Khadder NicholasVP, General Counsel & Corp Sec · 5 transactions | — | 3.8Kas of Jan 2025 | 3.5K | — | — |
| Carbone BarbaraDirector · 1 transaction | — | 3.0K | 3.0K | — | — |
| Drury Mark JVP, General Counsel & Sec. · 10 transactions | +102.7% | 2.2Kas of Jan 2022 | 1.1K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 5 years: -740.1K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.